ACHARYA Group is a long-standing manufacturer in the pharmaceutical industry, with a history dating back to 1975. Specializing in the production, contract research, and custom manufacturing of Active Pharmaceutical Ingredients, Intermediates, and Specialty chemicals, the company has achieved an impressive annual turnover of Rs.125 crores (USD 18 million), primarily driven by global exports, which account for more than 90% of its revenue. Notably, 95% of its exports are directed towards the Europe and USA markets, demonstrating a strong presence in these regions. The company's commitment to Research and Development is a cornerstone of its operations, supported by advanced instrumentation facilities. ACHARYA Group operates from four manufacturing sites in India, collectively boasting a monthly production capacity of 300TPM of Chemical Entities. Furthermore, many of its products hold approvals with DMF, and its sites are endorsed by prominent multinational companies, highlighting its adherence to international quality standards. ACHARYA Group's expertise extends across a diverse range of chemical unit processes, encompassing plant scale column chromatography, carbohydrate chemistry, natural product extraction, and other intricate synthetic chemical reactions, all geared towards producing high-purity compounds. Overall, ACHARYA Group stands as a formidable player in the pharmaceutical industry, leveraging its extensive manufacturing capabilities, robust R&D infrastructure, and a proven track record in global exports to drive its growth and success.
There is no investment information
No recent news or press coverage available for ACHARYA Group.